Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy - Wikidata - awgldk - TriplyDB

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy

http://www.wikidata.org/entity/Q36544801

about

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy Predictive value of neutrophil-to-lymphocyte ratio in diagnosis of prostate cancer among men who underwent template-guided prostate biopsy: A STROBE-compliant study.Author reply: The neutrophil-to-lymphocyte ratio in clinical practice.The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6 Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer.Sex-dependent association of preoperative hematologic markers with glioma grade and progression.Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis.

P2860

Q26751553-13A97ADD-BC5F-4FD5-94F9-84240BC1A996 Q32187187-41B770FA-15B2-4F67-B5FF-5746DF4DCE7F Q36864218-757B7C26-990C-4D2D-BD2A-55A0EBCBD182 Q39178017-12A3A12B-611D-471D-A5D4-097B0B76FF44 Q40460665-C6A0B630-1C89-4172-B10F-E393F1C3C1A3 Q41625490-D26F18E7-BDBF-4599-93D3-C222B690B5C6 Q41691026-64E2690D-70B8-487E-816E-491ABBBF9F64 Q42202612-2FEC161D-EDA9-470B-88F1-BAD729E0EE3C Q47562272-B5DE9166-FBED-48BE-9A8E-81DE89AB90E6 Q49919238-665A936F-9ED8-46B1-AC84-81515D1A3A68 Q55265420-5EECFDCA-CF94-42A5-AEC7-030600036239

P2860

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy

http://www.wikidata.org/entity/Q36544801

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Neutrophil-to-lymphocyte ratio ...... n men undergoing needle biopsy

@ast

Neutrophil-to-lymphocyte ratio ...... n men undergoing needle biopsy

@en

type

label

Neutrophil-to-lymphocyte ratio ...... n men undergoing needle biopsy

@ast

Neutrophil-to-lymphocyte ratio ...... n men undergoing needle biopsy

@en

prefLabel

Neutrophil-to-lymphocyte ratio ...... n men undergoing needle biopsy

@ast

Neutrophil-to-lymphocyte ratio ...... n men undergoing needle biopsy

@en

P1433

Q36544801-A601BDB2-3114-4A9C-8ACD-98957924EA7A

P1476

Q36544801-2A3C8BDA-D84E-4767-ACC6-00F5AA46512E

P2093

Q36544801-0C54250E-4A4E-4C63-B267-9E69D1EC7937

Q36544801-20826D3D-4BE5-459C-9A47-79A58FFCD901

Q36544801-238A99FC-BCF2-4718-A16C-1296225C08FC

Q36544801-307DAAE9-85CB-47BE-817E-FC82A6293646

Q36544801-478EB669-42F4-4E93-AC44-01A4166E7B66

Q36544801-4FAF471A-0D19-4B9D-A57D-714D1B389DC5

Q36544801-645823F3-4A5D-46A0-9DFF-74D308A045C6

Q36544801-6E29E599-0C4C-4BC9-8DAD-C0B66F9AADF8

Q36544801-71BA0D67-1ED9-49B1-87B4-444A66EEF9BC

Q36544801-78DFC693-6C16-428C-9890-E868C5F2572B

P2860

Q36544801-11D5A066-89EA-459C-89DB-565BEC552B17

Q36544801-174F1F10-33EF-4F1B-BAF0-7D81C1EF0124

Q36544801-1D7911CE-36F8-49E0-9CF0-546A6A546C90

Q36544801-2238AFA2-65BD-41B8-B6A5-8C6B2BB76BDF

Q36544801-2F4AE380-C6BF-4DB5-AE94-9914273280EE

Q36544801-31B6BC76-932C-463C-B789-413457C3EAAB

Q36544801-39283294-EEB9-4AF3-9D46-A44D1AD3C971

Q36544801-446E79C6-1F2F-4119-9624-F88FBAC0898D

Q36544801-44D15D24-EEDD-4382-815F-25109A0A6434

Q36544801-515D7E16-D10C-44F5-98EE-CC8318F13D3F

P304

Q36544801-FDF2923D-2477-4193-9322-ED2F9066E32D

P31

Q36544801-1605F242-D12E-433C-BA77-74B250C04294

P356

Q36544801-436FC246-CAE2-47F0-B4F4-9640CAB11128

P407

Q36544801-239F9955-0775-49E7-9162-B7D06280366D

P433

Q36544801-0B7D5E6A-6680-4CD5-B7FC-4B766628B69A

P478

Q36544801-5F7BD868-F18C-4167-83CB-775162EF75C4

P50

Q36544801-14563160-336A-4D66-880B-F7BE98980C6A

P577

Q36544801-B2D88C7D-7A9A-4471-B6AD-16AD821483DB

P5875

Q36544801-3991D5BF-3BF1-4FF1-AD68-61812075D6B6

P698

Q36544801-E781AD09-2A54-44A4-946C-9B0873EB3733

P932

Q36544801-ECB3700F-D317-4C15-95CD-46D77B000DAB

P356

ONCOTARGET.5081

P1433

P1476

Neutrophil-to-lymphocyte ratio ...... n men undergoing needle biopsy

@en

P2093

Hiroji Uemura

http://www.w3.org/2001/XMLSchema#string

Hiroki Ito

http://www.w3.org/2001/XMLSchema#string

Kazuhide Makiyama

http://www.w3.org/2001/XMLSchema#string

Kentaro Sakamaki

http://www.w3.org/2001/XMLSchema#string

Koji Izumi

http://www.w3.org/2001/XMLSchema#string

Masahiro Yao

http://www.w3.org/2001/XMLSchema#string

Naohito Kobayashi

http://www.w3.org/2001/XMLSchema#string

Noboru Nakaigawa

http://www.w3.org/2001/XMLSchema#string

Sachi Fukui

http://www.w3.org/2001/XMLSchema#string

Takashi Kawahara

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma

Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients

Inflammation and cancer

Cancer-related inflammation

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.

Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.

Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Risk factors for metastatic castration-resistant prostate cancer (CRPC) predict long-term treatment with docetaxel

P304

32169-32176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5081

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Hiroshi Miyamoto

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281680368

http://www.w3.org/2001/XMLSchema#string

P698

26359354

http://www.w3.org/2001/XMLSchema#string

P932

4741667

http://www.w3.org/2001/XMLSchema#string